시장조사 보고서 : 세계의 호흡 곤란 증후군 시장예측 2021년-2026년

■ 영문 제목 : Global Respiratory Distress Syndrome Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02292 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 87 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 호흡 곤란 증후군의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (포락탄트, 알파, 베락탄테, 칼락탄테, 기타)와 용도별 시장규모 (미숙아, 중등도~후기 조산, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 호흡 곤란 증후군 시장 점유율
- 지역별 호흡 곤란 증후군 시장규모
- 주요지역의 종류별 시장규모 (포락탄트, 알파, 베락탄테, 칼락탄테, 기타)
- 주요지역의 용도별 시장규모 (미숙아, 중등도~후기 조산, 기타)
- 미주의 호흡 곤란 증후군 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 호흡 곤란 증후군 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 호흡 곤란 증후군 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 호흡 곤란 증후군 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 호흡 곤란 증후군 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Respiratory Distress Syndrome will have significant change from previous year. By the most conservative estimates of global Respiratory Distress Syndrome market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 350.9 million in 2020. Over the next five years the Respiratory Distress Syndrome market will register a 5.7% CAGR in terms of revenue, the global market size will reach US$ 438.1 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Respiratory Distress Syndrome market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Poractant Alfa
Beractant
Calfactant
Others
Poractant Alpha’s largest market share is broken down to 67%.

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Very Preterm Infants
Moderate to Late Preterm Infants
Others
Very Preterm shapes the largest segment of the application market

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Chiesi Farmaceutici
CR-Double Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Respiratory Distress Syndrome Market Size 2016-2026
2.1.2 Respiratory Distress Syndrome Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Respiratory Distress Syndrome Segment by Type
2.2.1 Poractant Alfa
2.2.2 Poractant Alfa
2.2.3 Calfactant
2.2.4 Others
2.3 Respiratory Distress Syndrome Market Size by Type
2.3.1 Global Respiratory Distress Syndrome Market Size CAGR by Type
2.3.2 Global Respiratory Distress Syndrome Market Size Market Share by Type (2016-2021)
2.4 Respiratory Distress Syndrome Segment by Application
2.4.1 Very Preterm Infants
2.4.2 Moderate to Late Preterm Infants
2.4.3 Others
2.5 Respiratory Distress Syndrome Market Size by Application
2.5.1 Global Respiratory Distress Syndrome Market Size CAGR by Application
2.5.2 Global Respiratory Distress Syndrome Market Size Market Share by Application (2016-2021)

3 Respiratory Distress Syndrome Market Size by Players
3.1 Respiratory Distress Syndrome Market Size Market Share by Players
3.1.1 Global Respiratory Distress Syndrome Revenue by Players (2019-2021E)
3.1.2 Global Respiratory Distress Syndrome Revenue Market Share by Players (2019-2021E)
3.2 Global Respiratory Distress Syndrome Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Respiratory Distress Syndrome by Regions
4.1 Respiratory Distress Syndrome Market Size by Regions (2016-2021)
4.2 Americas Respiratory Distress Syndrome Market Size Growth (2016-2021)
4.3 APAC Respiratory Distress Syndrome Market Size Growth (2016-2021)
4.4 Europe Respiratory Distress Syndrome Market Size Growth (2016-2021)
4.5 Middle East & Africa Respiratory Distress Syndrome Market Size Growth (2016-2021)

5 Americas
5.1 Americas Respiratory Distress Syndrome Market Size by Country (2016-2021)
5.2 Americas Respiratory Distress Syndrome Market Size by Type (2016-2021)
5.3 Americas Respiratory Distress Syndrome Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Respiratory Distress Syndrome Market Size by Region (2016-2021)
6.2 APAC Respiratory Distress Syndrome Market Size by Type (2016-2021)
6.3 APAC Respiratory Distress Syndrome Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Respiratory Distress Syndrome by Country (2016-2021)
7.2 Europe Respiratory Distress Syndrome Market Size by Type (2016-2021)
7.3 Europe Respiratory Distress Syndrome Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Respiratory Distress Syndrome by Region (2016-2021)
8.2 Middle East & Africa Respiratory Distress Syndrome Market Size by Type (2016-2021)
8.3 Middle East & Africa Respiratory Distress Syndrome Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Respiratory Distress Syndrome Market Forecast
10.1 Global Respiratory Distress Syndrome Forecast by Regions (2021-2026)
10.1.1 Global Respiratory Distress Syndrome Forecast by Regions (2021-2026)
10.1.2 Americas Respiratory Distress Syndrome Forecast
10.1.3 APAC Respiratory Distress Syndrome Forecast
10.1.4 Europe Respiratory Distress Syndrome Forecast
10.1.5 Middle East & Africa Respiratory Distress Syndrome Forecast
10.2 Americas Respiratory Distress Syndrome Forecast by Countries (2021-2026)
10.2.1 United States Respiratory Distress Syndrome Market Forecast
10.2.2 Canada Respiratory Distress Syndrome Market Forecast
10.2.3 Mexico Respiratory Distress Syndrome Market Forecast
10.2.4 Brazil Respiratory Distress Syndrome Market Forecast
10.3 APAC Respiratory Distress Syndrome Forecast by Region (2021-2026)
10.3.1 China Respiratory Distress Syndrome Market Forecast
10.3.2 Japan Respiratory Distress Syndrome Market Forecast
10.3.3 Korea Respiratory Distress Syndrome Market Forecast
10.3.4 Southeast Asia Respiratory Distress Syndrome Market Forecast
10.3.5 India Respiratory Distress Syndrome Market Forecast
10.3.6 Australia Respiratory Distress Syndrome Market Forecast
10.4 Europe Respiratory Distress Syndrome Forecast by Country (2021-2026)
10.4.1 Germany Respiratory Distress Syndrome Market Forecast
10.4.2 France Respiratory Distress Syndrome Market Forecast
10.4.3 UK Respiratory Distress Syndrome Market Forecast
10.4.4 Italy Respiratory Distress Syndrome Market Forecast
10.4.5 Russia Respiratory Distress Syndrome Market Forecast
10.5 Middle East & Africa Respiratory Distress Syndrome Forecast by Region (2021-2026)
10.5.1 Egypt Respiratory Distress Syndrome Market Forecast
10.5.2 South Africa Respiratory Distress Syndrome Market Forecast
10.5.3 Israel Respiratory Distress Syndrome Market Forecast
10.5.4 Turkey Respiratory Distress Syndrome Market Forecast
10.5.5 GCC Countries Respiratory Distress Syndrome Market Forecast
10.6 Global Respiratory Distress Syndrome Forecast by Type (2021-2026)
10.7 Global Respiratory Distress Syndrome Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Chiesi Farmaceutici
11.1.1 Chiesi Farmaceutici Company Information
11.1.2 Chiesi Farmaceutici Respiratory Distress Syndrome Product Offered
11.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Chiesi Farmaceutici Main Business Overview
11.1.5 Chiesi Farmaceutici Latest Developments
11.2 CR-Double Crane
11.2.1 CR-Double Crane Company Information
11.2.2 CR-Double Crane Respiratory Distress Syndrome Product Offered
11.2.3 CR-Double Crane Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 CR-Double Crane Main Business Overview
11.2.5 CR-Double Crane Latest Developments
11.3 ONY Biotech
11.3.1 ONY Biotech Company Information
11.3.2 ONY Biotech Respiratory Distress Syndrome Product Offered
11.3.3 ONY Biotech Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 ONY Biotech Main Business Overview
11.3.5 ONY Biotech Latest Developments
11.4 AbbVie
11.4.1 AbbVie Company Information
11.4.2 AbbVie Respiratory Distress Syndrome Product Offered
11.4.3 AbbVie Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 AbbVie Main Business Overview
11.4.5 AbbVie Latest Developments
11.5 Yuhan Corporation
11.5.1 Yuhan Corporation Company Information
11.5.2 Yuhan Corporation Respiratory Distress Syndrome Product Offered
11.5.3 Yuhan Corporation Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Yuhan Corporation Main Business Overview
11.5.5 Yuhan Corporation Latest Developments
11.6 JW Pharmaceuticals
11.6.1 JW Pharmaceuticals Company Information
11.6.2 JW Pharmaceuticals Respiratory Distress Syndrome Product Offered
11.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 JW Pharmaceuticals Main Business Overview
11.6.5 JW Pharmaceuticals Latest Developments
11.7 Noargen
11.7.1 Noargen Company Information
11.7.2 Noargen Respiratory Distress Syndrome Product Offered
11.7.3 Noargen Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Noargen Main Business Overview
11.7.5 Noargen Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Respiratory Distress Syndrome Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Poractant Alfa
Table 3. Major Players of Beractant
Table 4. Major Players of Calfactant
Table 5. Major Players of Others
Table 6. Respiratory Distress Syndrome Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 7. Global Respiratory Distress Syndrome Market Size by Type (2016-2021) & ($ Millions)
Table 8. Global Respiratory Distress Syndrome Market Size Market Share by Type (2016-2021)
Table 9. Respiratory Distress Syndrome Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 10. Global Respiratory Distress Syndrome Market Size by Application (2016-2021) & ($ Millions)
Table 11. Global Respiratory Distress Syndrome Market Size Market Share by Application (2016-2021)
Table 12. Global Respiratory Distress Syndrome Revenue by Players (2019-2021E) & ($ Millions)
Table 13. Global Respiratory Distress Syndrome Revenue Market Share by Players (2019-2021E)
Table 14. Respiratory Distress Syndrome Key Players Head office and Products Offered
Table 15. Respiratory Distress Syndrome Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Respiratory Distress Syndrome Market Size by Regions 2016-2021 & ($ Millions)
Table 19. Global Respiratory Distress Syndrome Market Size Market Share by Regions 2016-2021
Table 20. Americas Respiratory Distress Syndrome Market Size by Country (2016-2021) & ($ Millions)
Table 21. Americas Respiratory Distress Syndrome Market Size Market Share by Country (2016-2021)
Table 22. Americas Respiratory Distress Syndrome Market Size by Type (2016-2021) & ($ Millions)
Table 23. Americas Respiratory Distress Syndrome Market Size Market Share by Type (2016-2021)
Table 24. Americas Respiratory Distress Syndrome Market Size by Application (2016-2021) & ($ Millions)
Table 25. Americas Respiratory Distress Syndrome Market Size Market Share by Application (2016-2021)
Table 26. APAC Respiratory Distress Syndrome Market Size by Region (2016-2021) & ($ Millions)
Table 27. APAC Respiratory Distress Syndrome Market Size Market Share by Region (2016-2021)
Table 28. APAC Respiratory Distress Syndrome Market Size by Type (2016-2021) & ($ Millions)
Table 29. APAC Respiratory Distress Syndrome Market Size Market Share by Type (2016-2021)
Table 30. APAC Respiratory Distress Syndrome Market Size by Application (2016-2021) & ($ Millions)
Table 31. APAC Respiratory Distress Syndrome Market Size Market Share by Application (2016-2021)
Table 32. Europe Respiratory Distress Syndrome Market Size by Country (2016-2021) & ($ Millions)
Table 33. Europe Respiratory Distress Syndrome Market Size Market Share by Country (2016-2021)
Table 34. Europe Respiratory Distress Syndrome Market Size by Type (2016-2021) & ($ Millions)
Table 35. Europe Respiratory Distress Syndrome Market Size Market Share by Type (2016-2021)
Table 36. Europe Respiratory Distress Syndrome Market Size by Application (2016-2021) & ($ Millions)
Table 37. Europe Respiratory Distress Syndrome Market Size Market Share by Application (2016-2021)
Table 38. Middle East & Africa Respiratory Distress Syndrome Market Size by Region (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Respiratory Distress Syndrome Market Size Market Share by Region (2016-2021)
Table 40. Middle East & Africa Respiratory Distress Syndrome Market Size by Type (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Respiratory Distress Syndrome Market Size Market Share by Type (2016-2021)
Table 42. Middle East & Africa Respiratory Distress Syndrome Market Size by Application (2016-2021) & ($ Millions)
Table 43. Middle East & Africa Respiratory Distress Syndrome Market Size Market Share by Application (2016-2021)
Table 44. Key and Potential Regions of Respiratory Distress Syndrome
Table 45. Key Application and Potential Industries of Respiratory Distress Syndrome
Table 46. Key Challenges of Respiratory Distress Syndrome
Table 47. Key Trends of Respiratory Distress Syndrome
Table 48. Global Respiratory Distress Syndrome Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 49. Global Respiratory Distress Syndrome Market Size Market Share Forecast by Regions (2021-2026)
Table 50. Global Respiratory Distress Syndrome Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 51. Global Respiratory Distress Syndrome Market Size Market Share Forecast by Type (2021-2026)
Table 52. Global Respiratory Distress Syndrome Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 53. Global Respiratory Distress Syndrome Market Size Market Share Forecast by Application (2021-2026)
Table 54. Chiesi Farmaceutici Details, Company Type, Respiratory Distress Syndrome Area Served and Its Competitors
Table 55. Chiesi Farmaceutici Respiratory Distress Syndrome Product Offered
Table 56. Chiesi Farmaceutici Respiratory Distress Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 57. Chiesi Farmaceutici Main Business
Table 58. Chiesi Farmaceutici Latest Developments
Table 59. CR-Double Crane Details, Company Type, Respiratory Distress Syndrome Area Served and Its Competitors
Table 60. CR-Double Crane Respiratory Distress Syndrome Product Offered
Table 61. CR-Double Crane Main Business
Table 62. CR-Double Crane Respiratory Distress Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 63. CR-Double Crane Latest Developments
Table 64. ONY Biotech Details, Company Type, Respiratory Distress Syndrome Area Served and Its Competitors
Table 65. ONY Biotech Respiratory Distress Syndrome Product Offered
Table 66. ONY Biotech Main Business
Table 67. ONY Biotech Respiratory Distress Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 68. ONY Biotech Latest Developments
Table 69. AbbVie Details, Company Type, Respiratory Distress Syndrome Area Served and Its Competitors
Table 70. AbbVie Respiratory Distress Syndrome Product Offered
Table 71. AbbVie Main Business
Table 72. AbbVie Respiratory Distress Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 73. AbbVie Latest Developments
Table 74. Yuhan Corporation Details, Company Type, Respiratory Distress Syndrome Area Served and Its Competitors
Table 75. Yuhan Corporation Respiratory Distress Syndrome Product Offered
Table 76. Yuhan Corporation Main Business
Table 77. Yuhan Corporation Respiratory Distress Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 78. Yuhan Corporation Latest Developments
Table 79. JW Pharmaceuticals Details, Company Type, Respiratory Distress Syndrome Area Served and Its Competitors
Table 80. JW Pharmaceuticals Respiratory Distress Syndrome Product Offered
Table 81. JW Pharmaceuticals Main Business
Table 82. JW Pharmaceuticals Respiratory Distress Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 83. JW Pharmaceuticals Latest Developments
Table 84. Noargen Details, Company Type, Respiratory Distress Syndrome Area Served and Its Competitors
Table 85. Noargen Respiratory Distress Syndrome Product Offered
Table 86. Noargen Main Business
Table 87. Noargen Respiratory Distress Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 88. Noargen Latest Developments
List of Figures
Figure 1. Respiratory Distress Syndrome Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Respiratory Distress Syndrome Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Respiratory Distress Syndrome Market Size Market Share by Type in 2020
Figure 7. Respiratory Distress Syndrome in Very Preterm Infants
Figure 8. Global Respiratory Distress Syndrome Market: Very Preterm Infants (2016-2021) & ($ Millions)
Figure 9. Respiratory Distress Syndrome in Moderate to Late Preterm Infants
Figure 10. Global Respiratory Distress Syndrome Market: Moderate to Late Preterm Infants (2016-2021) & ($ Millions)
Figure 11. Respiratory Distress Syndrome in Others
Figure 12. Global Respiratory Distress Syndrome Market: Others (2016-2021) & ($ Millions)
Figure 13. Global Respiratory Distress Syndrome Market Size Market Share by Application in 2020
Figure 14. Global Respiratory Distress Syndrome Revenue Market Share by Player in 2020
Figure 15. Global Respiratory Distress Syndrome Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Respiratory Distress Syndrome Market Size 2016-2021 ($ Millions)
Figure 17. APAC Respiratory Distress Syndrome Market Size 2016-2021 ($ Millions)
Figure 18. Europe Respiratory Distress Syndrome Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Respiratory Distress Syndrome Market Size 2016-2021 ($ Millions)
Figure 20. Americas Respiratory Distress Syndrome Market Size Market Share by Country in 2020
Figure 21. Americas Respiratory Distress Syndrome Market Size Market Share by Type in 2020
Figure 22. Americas Respiratory Distress Syndrome Market Size Market Share by Application in 2020
Figure 23. United States Respiratory Distress Syndrome Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Respiratory Distress Syndrome Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Respiratory Distress Syndrome Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Respiratory Distress Syndrome Market Size Market Share by Regions in 2020
Figure 27. APAC Respiratory Distress Syndrome Market Size Market Share by Type in 2020
Figure 28. APAC Respiratory Distress Syndrome Market Size Market Share by Application in 2020
Figure 29. China Respiratory Distress Syndrome Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Respiratory Distress Syndrome Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Respiratory Distress Syndrome Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Respiratory Distress Syndrome Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Respiratory Distress Syndrome Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Respiratory Distress Syndrome Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Respiratory Distress Syndrome Market Size Market Share by Country in 2020
Figure 36. Europe Respiratory Distress Syndrome Market Size Market Share by Type in 2020
Figure 37. Europe Respiratory Distress Syndrome Market Size Market Share by Application in 2020
Figure 38. Germany Respiratory Distress Syndrome Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Respiratory Distress Syndrome Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Respiratory Distress Syndrome Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Respiratory Distress Syndrome Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Respiratory Distress Syndrome Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Respiratory Distress Syndrome Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Respiratory Distress Syndrome Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Respiratory Distress Syndrome Market Size Market Share by Application in 2020
Figure 46. Egypt Respiratory Distress Syndrome Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Respiratory Distress Syndrome Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Respiratory Distress Syndrome Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Respiratory Distress Syndrome Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Respiratory Distress Syndrome Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 52. APAC Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 53. Europe Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 55. United States Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 56. Canada Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 59. China Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 60. Japan Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 61. Korea Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 63. India Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 64. Australia Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 65. Germany Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 66. France Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 67. UK Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 68. Italy Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 69. Russia Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 70. Spain Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 73. Israel Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Respiratory Distress Syndrome Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 호흡 곤란 증후군 시장예측 2021년-2026년] (코드 : LPI-2201K02292) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 호흡 곤란 증후군 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 과민성 대장증후군 (IBS) 시장예측 2021년-2026년
LPI-2201K00075 / LP Information / 2021년 12월 / 본 조사보고서는 과민성 대장증후군 (IBS)의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Irritable Bowel Syndrome (IBS) will have significant change from previous year. By the most conservative estimates of global Irritable Bowel Syndrome (IBS) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 4041...

세계의 볼프람 증후군 치료 시장예측 2021년-2026년
LPI-2201K02333 / LP Information / 2021년 12월 / 본 조사보고서는 볼프람 증후군 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Wolfram Syndrome Treatment will have significant change from previous year. By the most conservative estimates of global Wolfram Syndrome Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 호흡 유량 모니터링 제품 시장예측 2021년-2026년
LPI-2201K02554 / LP Information / 2021년 12월 / 본 조사보고서는 호흡 유량 모니터링 제품의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Respiratory Flow Monitoring Products will have significant change from previous year. By the most conservative estimates of global Respiratory Flow Monitoring Products market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 호흡기 관리 장치 시장예측 2021년-2026년
LPI-2201K02553 / LP Information / 2021년 12월 / 본 조사보고서는 호흡기 관리 장치의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Respiratory Care Device will have significant change from previous year. By the most conservative estimates of global Respiratory Care Device market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 21820 million in...

세계의 만성 호흡기 질환용 웨어러블 장치 시장예측 2021년-2026년
LPI-2201K02706 / LP Information / 2021년 12월 / 본 조사보고서는 만성 호흡기 질환용 웨어러블 장치의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of Wearable Chronic Respiratory Disease Device will have significant change from previous year. By the most conservative estimates of global Wearable Chronic Respiratory Disease Device market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from...

세계의 호흡 보조 장치 시장예측 2021년-2026년
LPI-2201K02552 / LP Information / 2021년 12월 / 본 조사보고서는 호흡 보조 장치의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Respiratory Assistance Devices will have significant change from previous year. By the most conservative estimates of global Respiratory Assistance Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...